These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 24384139)

  • 21. FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
    Guo X; Liu T; Zhao D; Wang X; Liu D; He Y; Shan C; Kong Y; Hu W; Tao B; Sun L; Zhao H; Li S; Liu J
    Neuroscience; 2017 Jul; 356():229-241. PubMed ID: 28504195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.
    Chong CM; Zhou ZY; Razmovski-Naumovski V; Cui GZ; Zhang LQ; Sa F; Hoi PM; Chan K; Lee SM
    Neurosci Lett; 2013 May; 543():121-5. PubMed ID: 23562886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells.
    Zhang D; Zhang JJ; Liu GT
    Eur J Pharmacol; 2007 Apr; 561(1-3):1-6. PubMed ID: 17359966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
    Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q
    Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
    Sun SY; An CN; Pu XP
    Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway.
    Zhang Y; Huang N; Chen M; Jin H; Nie J; Shi J; Jin F
    Biomed Pharmacother; 2019 Jun; 114():108789. PubMed ID: 30925459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism.
    Feng W; Wei H; Liu GT
    Mol Neurobiol; 2005; 31(1-3):295-300. PubMed ID: 15953829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
    Ayadi AE; Zigmond MJ; Smith AD
    Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J; Sharma MK; Gengler S; Hölscher C
    Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.
    Bao XQ; Wang XL; Zhang D
    Mol Neurobiol; 2017 Jan; 54(1):349-361. PubMed ID: 26742515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.
    Gong L; Zhang QL; Zhang N; Hua WY; Huang YX; Di PW; Huang T; Xu XS; Liu CF; Hu LF; Luo WF
    J Neurochem; 2012 Dec; 123(5):876-85. PubMed ID: 23094836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease.
    Farzam SA; Darabi S; Haghdoost-Yazdi H; Zaferani Y
    Neurol Res; 2024 Aug; 46(8):763-771. PubMed ID: 38740025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.
    Ribeiro RP; Moreira EL; Santos DB; Colle D; Dos Santos AA; Peres KC; Figueiredo CP; Farina M
    Neurochem Res; 2013 Mar; 38(3):660-8. PubMed ID: 23334712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.